Stock Scorecard
Stock Summary for OptimizeRx Corp (OPRX) - $8.64 as of 3/28/2025 8:38:58 PM EST
Total Score
8 out of 30
Safety Score
34 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for OPRX
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for OPRX
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for OPRX
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for OPRX
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for OPRX (34 out of 100)
Stock Price Rating (Max of 10) | 4 |
Historical Stock Price Rating (Max of 10) | 9 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 4 |
Book Value to Price (Max of 10) | 1 |
Analyst Buy Ratings (Max of 5) | 4 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 3 |
Trading Volume (Max of 10) | 4 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for OPRX
Financial Details for OPRX
Company Overview |
|
---|---|
Ticker | OPRX |
Company Name | OptimizeRx Corp |
Country | USA |
Description | OptimizeRx Corporation is a digital health company providing communications solutions for life sciences companies, physicians, and patients. The company is headquartered in Rochester, Michigan. |
Sector Name | TRADE & SERVICES |
Industry Name | SERVICES-BUSINESS SERVICES, NEC |
Most Recent Quarter | 12/31/2024 |
Next Earnings Date | 5/12/2025 |
Stock Price History |
|
Last Day Price | 8.64 |
Price 4 Years Ago | 62.11 |
Last Day Price Updated | 3/28/2025 8:38:58 PM EST |
Last Day Volume | 200,589 |
Average Daily Volume | 865,906 |
52-Week High | 14.13 |
52-Week Low | 3.78 |
Last Price to 52 Week Low | 128.57% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 60.34 |
Sector PE | 49.43 |
5-Year Average PE | 82.23 |
Free Cash Flow Ratio | 9.93 |
Industry Free Cash Flow Ratio | 102.24 |
Sector Free Cash Flow Ratio | 86.57 |
Current Ratio Most Recent Quarter | 3.23 |
Total Cash Per Share | 0.87 |
Book Value Per Share Most Recent Quarter | 6.34 |
Price to Book Ratio | 1.38 |
Industry Price to Book Ratio | 8.45 |
Sector Price to Book Ratio | 8.93 |
Price to Sales Ratio Twelve Trailing Months | 1.75 |
Industry Price to Sales Ratio Twelve Trailing Months | 3.70 |
Sector Price to Sales Ratio Twelve Trailing Months | 1.97 |
Analyst Buy Ratings | 4 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 18,490,400 |
Market Capitalization | 159,757,056 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -66.80% |
Annual Earnings Growth | -53.57% |
Reported EPS 12 Trailing Months | -1.10 |
Reported EPS Past Year | 0.33 |
Reported EPS Prior Year | 0.25 |
Net Income Twelve Trailing Months | -24,173,406 |
Net Income Past Year | -17,565,866 |
Net Income Prior Year | -11,438,440 |
Quarterly Revenue Growth YOY | 13.90% |
5-Year Revenue Growth | 27.52% |
Operating Margin Twelve Trailing Months | 11.20% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 16,126,000 |
Total Cash Past Year | 13,852,456 |
Total Cash Prior Year | 74,140,506 |
Net Cash Position Most Recent Quarter | -20,664,000 |
Net Cash Position Past Year | -24,437,544 |
Long Term Debt Past Year | 38,290,000 |
Long Term Debt Prior Year | 0 |
Total Debt Most Recent Quarter | 36,790,000 |
Equity to Debt Ratio Past Year | 0.77 |
Equity to Debt Ratio Most Recent Quarter | 0.76 |
Total Stockholder Equity Past Year | 126,553,000 |
Total Stockholder Equity Prior Year | 126,111,000 |
Total Stockholder Equity Most Recent Quarter | 114,465,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -1,120,630 |
Free Cash Flow Per Share Twelve Trailing Months | -0.06 |
Free Cash Flow Past Year | -8,110,575 |
Free Cash Flow Prior Year | 10,409,513 |
Options |
|
Put/Call Ratio | 0.05 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.95 |
MACD Signal | 0.76 |
20-Day Bollinger Lower Band | 3.21 |
20-Day Bollinger Middle Band | 5.69 |
20-Day Bollinger Upper Band | 8.18 |
Beta | 1.31 |
RSI | 65.91 |
50-Day SMA | 7.79 |
150-Day SMA | 12.95 |
200-Day SMA | 23.99 |
System |
|
Modified | 3/28/2025 4:05:09 AM EST |